关注
Kelan Hlavaty
Kelan Hlavaty
SQZ Biotechnologies
在 u.northwestern.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Transforming growth factor-beta 1 delivery from microporous scaffolds decreases inflammation post-implant and enhances function of transplanted islets
JMH Liu, J Zhang, X Zhang, KA Hlavaty, CF Ricci, JN Leonard, LD Shea, ...
Biomaterials 80, 11-19, 2016
1192016
Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation
J Bryant, KA Hlavaty, X Zhang, WT Yap, L Zhang, LD Shea, X Luo
Biomaterials 35 (31), 8887-8894, 2014
1012014
Tolerance induction using nanoparticles bearing HY peptides in bone marrow transplantation
KA Hlavaty, DP McCarthy, E Saito, WT Yap, SD Miller, LD Shea
Biomaterials 76, 1-10, 2016
542016
Enhancing human islet transplantation by localized release of trophic factors from PLG scaffolds
KA Hlavaty, RF Gibly, X Zhang, CB Rives, JG Graham, WL Lowe Jr, X Luo, ...
American Journal of Transplantation 14 (7), 1523-1532, 2014
542014
Cellular and molecular targeting for nanotherapeutics in transplantation tolerance
KA Hlavaty, X Luo, LD Shea, SD Miller
Clinical Immunology 160 (1), 14-23, 2015
302015
Microfluidic squeezing enables MHC class I antigen presentation by diverse immune cells to elicit CD8+ T cell responses with antitumor activity
MG Booty, KA Hlavaty, A Stockmann, EI Ozay, C Smith, L Tian, E How, ...
The Journal of Immunology 208 (4), 929-940, 2022
132022
Intracellular delivery of biomolecules to modify immune response
S Loughhead, L Talarico, A Vicente-Suarez, M Booty, H Bernstein, ...
US Patent App. 16/980,339, 2021
32021
Methods for treating hpv-associated diseases
S Loughhead, L Talarico, A Vicente-Suarez, M Booty, H Bernstein, ...
US Patent App. 16/980,341, 2021
32021
169 Microfluidics cell squeezing enables human PBMCs as drivers of antigen-specific CD8 T responses across broad range of antigens for diverse clinical applications
M Maloney, S Loughhead, A Ramakrishnan, C Smith, A Venkitaraman, ...
Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020
32020
SQZing cells to rapidly generate antigen presenting cells (APC) for solid tumor immune therapies with efficient, scalable manufacturing
SM Loughhead, MG Booty, K Hlavaty, A Vicente-Suarez, K Blagovic, ...
Annals of Oncology 29, x13, 2018
32018
Engineering a new generation of cell therapies for solid tumor oncology using the SQZ platform
KA Hlavaty, MG Booty, S Loughhead, K Blagovic, A Vicente-Suarez, ...
Cancer Research 79 (13_Supplement), 3187-3187, 2019
22019
Intracellular delivery of biomolecules to enhance antigen presenting cell function
H Bernstein, M Booty, L Cassereau, J Chow, K Hlavaty, S Loughhead, ...
US Patent App. 17/282,709, 2021
12021
In Vivo Delivery of a CD20 CAR Using a CD8-Targeted Fusosome in Southern Pig-Tail Macaques (M. nemestrina) Results in B Cell Depletion
J Cunningham, S Chandra, A Emmanuel, A Mazzarelli, C Passaro, ...
Blood 138, 2769, 2021
12021
Abstract LB105: In vivo CAR T therapy: targeted in vivo gene delivery of a CAR using a CD8-specific fusogen results in tumor eradication
A Emmanuel, P Cruite, H Ennajdaoui, C Passaro, P Baldwin, V Duback, ...
Cancer Research 81 (13_Supplement), LB105-LB105, 2021
12021
Biomaterial Approaches for Immunomodulation to Enhance Transplantation Tolerance
KA Hlavaty
Northwestern University, 2015
12015
DELIVERY OF BIOMOLECULES TO PBMCs TO MODIFY AN IMMUNE RESPONSE
AR Sharei, H Bernstein, S Loughhead, M Booty, K Blagovic, K Hlavaty, ...
US Patent App. 18/318,842, 2024
2024
Delivery of biomolecules to PBMCs to modify an immune response
AR Sharei, H Bernstein, S Loughhead, M Booty, K Blagovic, K Hlavaty, ...
US Patent 11,692,168, 2023
2023
Formulations of pbmcs
H Bernstein, S Loughhead, M Booty, K Hlavaty, T Abdeljawad, M Dadgar, ...
US Patent App. 17/563,764, 2022
2022
Fusosome-Targeted Gene Transfer to Human Hepatocytes
M Stoppato, K Trudeau, K Sullivan, A Mazzarelli, C Cote, P Cruite, ...
MOLECULAR THERAPY 30 (4), 415-415, 2022
2022
Retargeted" Fusosomes" for In Vivo Delivery to T Cells
P Cruite, Z Frye, S Amatya, B Dolinski, B Granger, C Ciarlo, H Ennajdaoui, ...
MOLECULAR THERAPY 30 (4), 504-504, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–20